Uncategorised - European Medical Journal

Keep up to date with the genomic profiling in precision oncology

This series of educational webinars covers the latest developments in the precision medicine landscape in non-small cell lung cancer…

Hydrocortisone Fiber Patch: A 24-Hour Skin Solution

A cutting-edge alternative to traditional skin creams offers a promising new approach for treating inflammatory skin diseases.

New Pathway for OA Treatment: ACR24

Sodium channels in cartilage cells may hold the key to treating osteoarthritis (OA), a new study presented at ACR Convergence 2024 unveiled.

Workload Control Linked to Physician Burnout

Control over clinical work plays a critical role in preventing burnout and retaining U.S. physicians, as highlighted in a new study.

Colorectal Cancer Stool Testing in Underserved Communities

Mailed fecal immunochemical testing (FIT) kits using centralized outreach significantly increases colorectal cancer (CRC) screening rates in underserved communities, according to the results of a new study.

Clonazepam Recall Due To Strength Mislabeling

Clonazepam has been recalled due to potential product carton strength mislabeling. Endo Pharmaceuticals (Malvern, Pennsylvania) has issued a voluntary, nationwide recall of a specific lot of Clonazepam Orally Disintegrating Tablets (USP, C-IV).

Europe's biopharma SMEs need urgent support, warns EFPIA

Europe must act urgently to back small and medium-sized enterprises (SMEs) in the biopharmaceutical sector, says the EFPIA.

How Medical AI Bias Risks Patient Care

Bias in medical artificial intelligence (AI) poses a critical threat to equitable patient outcomes, according to recent research.

SGLT-2 Inhibitors Reduce Mortality in Diabetic Kidney Transplant Recipients

SGLT-2 inhibitors significantly lower mortality and adverse events in diabetic kidney transplant recipients, study reveals.

Elias Revonta, Orcason Medical

World AMR Awareness Week with Orcason Medical’s Elias Revonta

Elias Revonta, Founder & CEO, Orcason Medical, joins the podcast to discuss why the fight against AMR needs to extend beyond awareness weeks.